Ament S M C, Gillissen F, Maessen J M C, Dirksen C D, Bell A V R J, Vissers Y L J, van der Weijden T, von Meyenfeldt M F
CAPHRI, School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands; GROW, School for Oncology & Developmental Biology, Maastricht University Medical Centre, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.
CAPHRI, School for Public Health and Primary Care, Maastricht University Medical Centre, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands; GROW, School for Oncology & Developmental Biology, Maastricht University Medical Centre, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.
Breast. 2014 Aug;23(4):429-34. doi: 10.1016/j.breast.2014.02.010. Epub 2014 Apr 1.
Between 2005 and 2007 a short stay programme for breast cancer surgery was successfully implemented in early adopter hospitals. The current study evaluates the sustainability of this success five years following implementation. A retrospective audit of 160 consecutive patients undergoing breast cancer surgery was performed five years following implementation of short stay. The total proportion of patients treated in short stay was 82% (hospital 1 83%, hospital 2 78%, hospital 3 87%, hospital 4 80%) after five years follow-up, which was comparable to the proportion in short stay directly after implementation (p = 0.938). Overall compliance to the key recommendations to facilitate short stay after breast cancer surgery increased from 65% directly after implementation to 78% five years after implementation. This study shows that short stay after breast cancer surgery was successfully sustained in early adopter hospitals five years following implementation.
2005年至2007年期间,早期采用该方案的医院成功实施了乳腺癌手术短期住院计划。本研究评估了该成功方案实施五年后的可持续性。在实施短期住院计划五年后,对160例连续接受乳腺癌手术的患者进行了回顾性审计。五年随访后,短期住院治疗的患者总比例为82%(医院1为83%,医院2为78%,医院3为87%,医院4为80%),这与实施后直接进行短期住院治疗的比例相当(p = 0.938)。促进乳腺癌手术后短期住院的关键建议的总体依从性从实施后直接的65%提高到实施五年后的78%。本研究表明,在早期采用该方案的医院中,乳腺癌手术后的短期住院计划在实施五年后成功得以维持。